Valuation: Teva Pharmaceutical Industries Limited

Market Cap 51.92B 47.05B 43.52B 39.27B 74B 4,896B 76.61B 523B 207B 2,615B 195B 191B 8,302B P/E 2026 *
133x
P/E 2027 * 24.3x
Enterprise Value 63.89B 57.9B 53.55B 48.32B 91.06B 6,024B 94.27B 643B 255B 3,218B 240B 235B 10,215B EV / Sales 2026 *
3.81x
EV / Sales 2027 * 3.48x
Free-Float
91.3%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Teva Pharmaceutical Industries Limited

Manager TitleAgeSince
Chief Executive Officer 57 01/01/2023
Director of Finance/CFO 53 22/12/2019
Chief Operating Officer 52 03/06/2024
Director TitleAgeSince
Director/Board Member 70 01/01/2009
Chairman 78 06/02/2017
Director/Board Member 65 01/09/2015
Date Insider Type Main position Quantity % Market Cap. Importance
5/8/26 Sell

Director

-17 0.0000%
3/8/26 Exercice

Chief Technology Officer

131,066 0.0112%
3/8/26 Exercice

Head of Human Resources

38,481 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+2.04%+2.01% - - 51.92B
+1.26%+6.61%+40.79%+145.27% 1,286B
+0.79%+3.45%+45.84%+92.04% 688B
+0.20%+1.28%+26.97%+114.41% 521B
-0.44%+3.69%+41.45%+70.04% 386B
+0.55%+0.70%+59.02%+45.79% 364B
-0.12%+0.74%+28.39%+60.32% 302B
+0.37%+0.37%+3.33%+38.57% 287B
-0.30%+1.14%+38.29%+70.56% 252B
+0.08%+0.71%+34.44%+123.99% 208B
Average +0.44%+2.08%+35.39%+84.55% 477B
Weighted average by Cap. +0.56%+3.26%+37.70%+99.28%

Financials

2026 *2027 *
Net sales 16.79B 15.21B 14.07B 12.7B 23.93B 1,583B 24.77B 169B 67.03B 846B 63B 61.66B 2,684B 17.35B 15.72B 14.54B 13.12B 24.72B 1,636B 25.6B 175B 69.26B 874B 65.1B 63.72B 2,774B
Net income 483M 437M 405M 365M 688M 45.51B 712M 4.86B 1.93B 24.31B 1.81B 1.77B 77.17B 2.2B 1.99B 1.84B 1.66B 3.13B 207B 3.24B 22.14B 8.78B 111B 8.25B 8.08B 352B
Net Debt 11.97B 10.85B 10.03B 9.05B 17.06B 1,129B 17.66B 121B 47.79B 603B 44.92B 43.97B 1,914B 8.36B 7.58B 7.01B 6.33B 11.92B 789B 12.34B 84.22B 33.39B 421B 31.39B 30.72B 1,337B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Teva Pharmaceutical Industries Limited